Neurologist and neuroscientist by training. Brain-mapping researcher, healthcare executive, and entrepreneur — a career spent proving things in the world we can measure.
After years mapping the living brain for epilepsy and tumor surgery, I built and led companies across digital health and healthcare — raising capital, advising global institutions, and running hospital service lines. This is the 3D foundation. It is also exactly what makes the questions on the rest of this site worth taking seriously.
Postdoctoral Fellowship, Brain Mapping (2004–2006)
MBA — Finance & Health Care Systems (2006–2008)
Medical School (1995–2000)
Electrical Engineering (1992–1995)
PhD, Neuroscience (2004–2007)
Residency, Neurology (2001–2003)
Before the companies, there was the research: maps of the living brain, built so surgeons could operate on epilepsy and tumors without erasing the person. The work ran across three scales — single neurons, cortical circuits, and the whole brain.
An invited talk at the I Brazilian Congress of Brain, Emotions and Behavior — given alongside three lectures on functional neuroimaging of memory and motor function. The question was already public a decade before the heart attack that made it personal.
Patient-experience & digital-therapeutics company, building platforms with pharma (Novartis, Horizon).
An exam-delivery system bringing advanced exams — and quality virtual care — into the home.
A pioneering online medical-visits platform that kept Brazilian doctors with their patients through COVID-19.
One of Brazil's first cloud-deployed EMR systems — when "the cloud" was still just a fluffy thing in the sky.
Among the first internet resources for medical students in Brazil, built at UFRGS in 1995. The Epilepsy CD-ROM that followed won Microsoft's national multimedia prize — and an internship at Microsoft Argentina, working on electronic medical records.
Brazil's first web portal answering patients' medical questions — 100,000+ people reached; acquired by the RS Medical Association.
A venture-building practice that raised capital for health-technology companies (Bionexo, Medicinia), backed private-equity and venture deals, and provided intelligence to leading funds. Across different capacities — as operator, advisor, and board member — he has helped shape significant transactions in health and biotech. At Artiva Biotherapeutics, he served as the executive responsible for the company's financial planning through its IPO — owning the long-range plan that informed how much needed to be raised.
The more precisely I mapped the brain, the clearer its limit became. So I followed the question outward — into consciousness, meaning, and what lies beyond.